Pharmaceuticals
East Jerusalem pharmacy student indicted for plotting mass-casualty attack using poison
Prosecutors accused a pharmacy student from Beit Hanina of preparing terrorist attacks involving lethal poisons and explosive devices, allegedly intended to cause mass casualties.
Turkey probes Israeli pharmaceutical company Teva over claims it blocked rivals in drug market
Israeli PolyPid signs $320 million deal to sell drug preventing surgical infections in US, Canada
Europe, Israel, and the medical record of a nation - opinion
Health Ministry hides results from satisfactory service survey
The Health Ministry regularly distributes results following surveys regarding its external partners.
In light of coronavirus crisis, resilience is crucial, says Takeda GM
Arie Kramer spoke to 'The Jerusalem Post' about the role of Big Pharma in a health crisis, the importance of meriting people’s trust and what they are doing to help.
Hillel's Tech Corner: CytoReason: Where AI meets drug development
CytoReason’s technology uses a machine learning model to build a molecular level understanding of tissues in diseases on the cellular level.
Moderna, Pfizer start pivotal COVID-19 vaccine trials, eye year-end launch
The study is expected to include about 120 sites globally and could include up to 30,000 participants. It will include regions heavily impacted by COVID-19.
Pfizer, BioNTech say vaccine expected to be ready for approval by December
If it receives marketing approval, the companies are preparing to make up to 100 million doses by the end of 2020 and another 1.2 billion doses by the end of 2021.
BioNTech and Pfizer's COVID-19 vaccine shows potential in human trial
"These first trial results show that the vaccine yields immune activity and causes a strong immune response," said BioNTech's co-founder and Chief Executive Officer Ugur Sahin.
Canadian company Medicago develops plant-based coronavirus vaccine
The company has developed a unique method of creating a vaccine by letting plants do the work. "We're using plants as mini factories," said Natalie Charland, a senior director at Medicago.
Bayer to test new drugs on 3D-printed heart tissue at Tel Aviv University
The new method of testing bypasses many tedious screening methods, making it faster, cheaper and more efficient.
The Lounge March 10, 2020: SuperPharm
A number of Super Pharm’s managers attended the ceremony, and Kupler and Keshet arranged to meet again in the future to discuss continued cooperation.
After turbulent years, Teva CEO Schultz forecasts stability
Teva completed its two-year major restructuring plan in 2019, reducing its cost base by over $3 billion and net debt by more than $9b.
